Bharat Immunologicals Financial Statements Trends

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 19.90  0.70  3.65%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Bharat Immunologicals 
Money Received 
Discounts and Returns 
1.28 B

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd reported 1.28 B of revenue. This is much higher than that of the sector, and significantly higher than that of Revenue industry, The Revenue for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in cash and equivalents category among related companies. It is rated below average in shares outstanding category among related companies creating about  0.28  of Shares Outstanding per Cash and Equivalents. The ratio of Cash and Equivalents to Shares Outstanding for Bharat Immunologicals Biologicals Corp Ltd is roughly  3.53 

Peer Comparison

Bharat Immunologicals Cash per Share Comparison
Bharat Immunologicals is currently under evaluation in cash per share category among related companies.

Did you try this?

Run Crypto Portfolio Optimizer Now

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
Hide  View All  NextLaunch Crypto Portfolio Optimizer

Fundamental Indicators

Current Bharat Immunologicals financial ratios